Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Apyx Medical Corporation before investing.

In this article, we go over a few key elements for understanding Apyx Medical Corporation’s stock price such as:

• Apyx Medical Corporation’s current stock price and volume
• Why Apyx Medical Corporation’s stock price changed recently
• Upgrades and downgrades for APYX from analysts
• APYX’s stock price momentum as measured by its relative strength

About Apyx Medical Corporation (APYX)

Before we jump into Apyx Medical Corporation’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Want to learn more about Apyx Medical Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Apyx Medical Corporation.

Apyx Medical Corporation’s Stock Price as of Market Close

As of April 24, 2026, 4:00 PM, CST, Apyx Medical Corporation’s stock price was $3.720.

Apyx Medical Corporation is down 2.11% from its previous closing price of $3.800.

During the last market session, Apyx Medical Corporation’s stock traded between $3.700 and $3.830. Currently, there are approximately 42.16 million shares outstanding for Apyx Medical Corporation.

Apyx Medical Corporation’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Apyx Medical Corporation Stock Price History

Apyx Medical Corporation’s (APYX) price is currently up 0.81% so far this month.

During the month of April, Apyx Medical Corporation’s stock price has reached a high of $4.180 and a low of $3.500.

Over the last year, Apyx Medical Corporation has hit prices as high as $4.500 and as low as $0.825. Year to date, Apyx Medical Corporation’s stock is up 6.29%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Apyx Medical Corporation Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 24, 2026, there was 1 analyst who downgraded Apyx Medical Corporation’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Apyx Medical Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Apyx Medical Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Apyx Medical Corporation’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Apyx Medical Corporation (APYX) by visiting AAII Stock Evaluator.

Relative Price Strength of Apyx Medical Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 24, 2026, Apyx Medical Corporation has a weighted four-quarter relative price strength of 32.77%, which translates to a Momentum Score of 95 and is considered to be Very Strong.

Want to learn more about how Apyx Medical Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Apyx Medical Corporation Stock Price: Bottom Line

As of April 24, 2026, Apyx Medical Corporation’s stock price is $3.720, which is down 2.11% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Apyx Medical Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.